{"database": "openregs", "table": "documents", "rows": [["FDA-2026-P-5116-0005", "FDA", "FDA-2026-P-5116", "Appendix III - Hangas A, Aasumets K, Kek\u00e4l\u00e4inen NJ, Palohein\u00e4 M, Pohjoism\u00e4ki JLO, Gerhold JM. Ciprofloxacin impairs mitochondrial DNA replication initiation through inhibition of Topoisomerase 2. Pharmacol Res. 2018;132:101\u2013110.", "Supporting & Related Material", "Background Material", "2026-05-11T04:00:00Z", 2026, 5, null, null, "2026-05-11T23:22:14Z", null, 0, 0, "09000064b92c88fd"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2026-P-5116-0005"], "units": {}, "query_ms": 0.6547869998030365, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}